title: How women deal with the results of serum screening for Down syndrome in the second trimester of pregnancy.
abstract: To gain insight into how pregnant women experience serum screening for Down syndrome, we sent questionnaires to two groups of relevant subjects in the north of the Netherlands. The questionnaires addressed the following issues: decision-making process, knowledge and opinions. Questionnaire A was sent to women of 36 years of age and older (n=99) (group A) who were all 20 to 36 weeks pregnant at that time. In the Netherlands prenatal diagnosis is routinely available to these women. Questionnaire B was sent to women of younger than 36 years (n=69) (group B) who had received a screen-positive result and had subsequently undergone amniocentesis. About half of these women were still pregnant at that time. For these women, serum screening is only available on the basis of opting-in. The two questionnaires were largely identical. The response rates to questionnaires A and B were 82% and 91%, respectively. Group A (women of 36 years and older) considered that second trimester serum screening made a welcome contribution to the decision-making process about whether to undergo amniocentesis. Moreover, it reduced the amniocentesis rate considerably. The vast majority said they would apply for serum screening in a following pregnancy, but favoured the idea of first trimester screening. In group B (women of younger than 36 years), reassurance was the most commonly mentioned reason for undergoing serum screening. Almost all the women experienced some degree of anxiety when they were informed about the screen-positive result and 13% continued to be anxious, even after the favourable result of the amniocentesis. The majority of the respondents would also apply for serum screening in a following pregnancy and were of the opinion that this screening should be offered to all pregnant women in the Netherlands.
authors.affiliation: Antenatal Diagnosis Unit, Department of Obstetrics and Gynaecology, University Hospital Groningen, The Netherlands. m.j.n.weinans@og.azg.nl
authors.forename: M J
authors.initials: MJ
authors.lastname: Weinans
authors.forename: A M
authors.initials: AM
authors.lastname: Huijssoon
authors.forename: T
authors.initials: T
authors.lastname: Tymstra
authors.forename: M C
authors.initials: MC
authors.lastname: Gerrits
authors.forename: J R
authors.initials: JR
authors.lastname: Beekhuis
authors.forename: A
authors.initials: A
authors.lastname: Mantingh
mesh_terms: D000328:Adult; D000649:Amniocentesis / Q000523:psychology / Q000706:statistics & numerical data; D001007:Anxiety; D003657:Decision Making; D004314:Down Syndrome / Q000097:blood / Q000523:psychology*; D005260:Female; D006801:Humans; D007721:Knowledge of Results, Psychological; D008403:Mass Screening; D009426:Netherlands; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011296:Prenatal Diagnosis / Q000523:psychology*; D011795:Surveys and Questionnaires